Abstract:Keratins, the major structural protein of all epithelia are a diverse group of cytoskeletal scaffolding proteins that form intermediate filament networks, providing structural support to keratinocytes that maintain the integrity of the skin. Expression of keratin genes is usually regulated by differentiation of the epidermal cells within the stratifying squamous epithelium. Amongst the 54 known functional keratin genes in humans, about 22 different genes including, the cornea, hair and hair follicle-specific keratins have been implicated in a wide range of hereditary diseases. The exact phenotype of each disease usually reflects the spatial expression level and the types of mutated keratin genes, the location of the mutations and their consequences at sub-cellular levels as well as other epigenetic and/or environmental factors. The identification of specific pathogenic mutations in keratin disorders formed the basis of our understanding that led to re-classification, improved diagnosis with prognostic implications, prenatal testing and genetic counseling in severe keratin genodermatoses. Molecular defects in cutaneous keratin genes encoding for keratin intermediate filaments (KIFs) causes keratinocytes and tissue-specific fragility, accounting for a large number of genetic disorders in human skin and its appendages. These diseases are characterized by keratinocytes fragility (cytolysis), intra-epidermal blistering, hyperkeratosis, and keratin filament aggregation in severely affected tissues. Examples include epidermolysis bullosa simplex (EBS; K5, K14), keratinopathic ichthyosis (KPI; K1, K2, K10) i.e. epidermolytic ichthyosis (EI; K1, K10) and ichthyosis bullosa of Siemens (IBS; K2), pachyonychia congenita (PC; K6a, K6b, K16, K17), epidermolytic palmo-plantar keratoderma (EPPK; K9, (K1)), monilethrix (K81, K83, K86), ectodermal dysplasia (ED; K85) and steatocystoma multiplex. These keratins also have been identified to have roles in apoptosis, cell proliferation, wound healing, tissue polarity and remodeling. This review summarizes and discusses the clinical, ultrastructural, molecular genetics and biochemical characteristics of a broad spectrum of keratin-related genodermatoses, with special clinical emphasis on EBS, EI and PC. We also highlight current and emerging model tools for prognostic future therapies. Hopefully, disease modeling and in-depth understanding of the molecular pathogenesis of the diseases may lead to the development of novel therapies for several hereditary cutaneous diseases.

Update of the keratin gene family: evolution, tissue-specific expression patterns, and relevance to clinical disorders

Great Promises Yet to Be Fulfilled: Defining Keratin Intermediate Filament Function in Vivo.

Keratin gene mutations in disorders of human skin and its appendages

Human keratin diseases: the increasing spectrum of disease and subtlety of the phenotype-genotype correlation

Insights into genotype-phenotype correlation in pachyonychia congenita from the human intermediate filament mutation database

Keratins 6, 16, and 17 in Health and Disease: A Summary of Recent Findings

Keratin 17 in disease pathogenesis: from cancer to dermatoses: Keratin 17 in disease pathogenesis

Disturbed Keratin Expression And Distinct Genotype Of Ichthyosis Hystrix Lambert Type

Comprehensive RNA sequencing in primary murine keratinocytes and fibroblasts identifies novel biomarkers and provides potential therapeutic targets for skin-related diseases

A keratin scaffold regulates epidermal barrier formation, mitochondrial lipid composition, and activity

Mouse genetics identifies unique and overlapping functions of fibroblast growth factor receptors in keratinocytes

Keratin isoform shifts modulate motility signals during wound healing

A novel mouse type I intermediate filament gene, keratin 17n (K17n), exhibits preferred expression in nail tissue.

Update on the Kelch-like (KLHL) gene family

Molecular characterization and evolution of the SPRR family of keratinocyte differentiation markers encoding small proline-rich proteins.

Hair follicle differentiation: expression, structure and evolutionary conservation of the hair type II keratin intermediate filament gene family

Human keratin 1/10‐1B tetramer structures reveal a knob‐pocket mechanism in intermediate filament assembly

Organization and expression of hair follicle genes

Mutation of human keratin 18 in association with cryptogenic cirrhosis.

Genome-wide Identification, Characterization, and Expression Analysis of Keratin Genes (krts) Family in Yak (bos Grunniens)

The keratin 16 null phenotype is modestly impacted by genetic strain background in mice